Skip to content

Insider · CIK 0001713090

Stephen M Kanovsky

director

Files at NEO (NEOGENOMICS INC). First filing May 9, 2025, latest May 9, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$31k bought, $0 sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

NEO: NEOGENOMICS INC

NEOOct 9, 2026 · close 16.35

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
46Moderate
NEObuy 7
NEOGENOMICS INC
$31k
4,000 shares
+11%+25% from low-57% from high

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jun 1, 2025NEO
NEOGENOMICS INC
MOption exercise
Common Stock
+12,254$0.00$052,344Jun 3, 2025
Jun 1, 2025NEO
NEOGENOMICS INC
MOption exercise
Restricted Stock Unitderivative
-12,254$0.00$00Jun 3, 2025
Jun 1, 2025NEO
NEOGENOMICS INC
AGrant or award
Stock Option (Right to Buy)derivative
+16,107$0.00$016,107Jun 3, 2025
Jun 1, 2025NEO
NEOGENOMICS INC
AGrant or award
Restricted Stock Unitderivative
+23,077$0.00$023,077Jun 3, 2025
May 7, 2025NEO
NEOGENOMICS INC
POpen-market purchase
Common Stock
+4,000$7.78$31k40,090May 9, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Stephen M Kanovsky: insider trades and track record | InsiderTell